Skip to main content

Advertisement

SpringerLink
Log in

Advanced Technology IOL Cataract Surgery Optimized for Pre-existing Corneal Disease

  • Cataract (CE Starr and A Brissette, Section Editors)
  • Published:
Current Ophthalmology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Discuss the management of ocular surface disease for favorable outcomes with advanced technology IOLs.

Recent Findings

Ocular surface disease poses a challenge for favorable outcomes with advanced technology IOLs, especially given current patient expectations that glasses-free outcomes are guaranteed. Long-established and recent techniques for optimizing the ocular surface prior to cataract surgery, combined with education and careful selection of IOLs can help meet patient expectations.

Summary

Careful measurement, planning, and treatment of ocular surface disorders can enable more patients to benefit from advanced technology IOLs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Patino CM, McKean-Cowdin R, Azen SP, Allison JC, Choudhury F, Varma R, et al. Central and peripheral visual impairment and the risk of falls and falls with injury. Ophthalmology. 2010;117(2):199–206.e1 Patients with presbyopia-correcting IOLs may benefit from both cosmetic and functional improvements with increased safety compared to bifocals, which create peripheral visual distortion, thereby increasing the risk of falls.

    Article  PubMed  Google Scholar 

  2. Sangwan VS, Gupta S, Das S. Cataract surgery in ocular surface diseases: clinical challenges and outcomes. Curr Opin Ophthalmol. 2018;29(1):81–7.

    Article  PubMed  Google Scholar 

  3. Kim P, Plugfelder S, Slomovic AR. Top 5 pearls to consider when implanting advanced-technology IOLs in patients with ocular surface disease. Int Ophthalmol Clin. 2012;52(2):51–8.

    Article  PubMed  Google Scholar 

  4. Garcia-Zalisnak D, Nash D, Yeu E. Ocular surface diseases and corneal refractive surgery. Curr Opin Ophthalmol. 2014;25(4):264–9.

    Article  PubMed  Google Scholar 

  5. •• Gibbons A, Ali TK, Waren DP, Donaldson KE. Causes and correction of dissatisfaction after implantation of presbyopia-correcting intraocular lenses. Clin Ophthalmol (Auckland, NZ). 2016;10:1965 Clinical retrospective analysis of 74 eyes in 49 patients documents that residual refractive error and dry eye, both a reflection of irregular astigmatism and biometric inaccuracies, are the main sources of patient dissatisfaction with multifocal IOL surgery.

    Article  Google Scholar 

  6. de Silva SR, Evans JR, Kirthi V, Ziaei M, Leyland M. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev 2016;12:CD003169.

  7. Aristeidou A, Taniguchi EV, Tsatsos M, Muller R, McAlinden C, Pineda R, et al. The evolution of corneal and refractive surgery with the femtosecond laser. Eye Vis (Lond). 2015;2:12. https://doi.org/10.1186/s40662-015-0022-6.

    Article  Google Scholar 

  8. Epitropoulos AT. Visual and refractive outcomes of a toric presbyopia-correcting intraocular lens. J Ophthalmol. 2016;2016:1–6.

    Article  Google Scholar 

  9. Gokce SE, Gumus K, Garibay A, Al-Mohtaseb ZN. Cataract surgery in the setting of corneal pathology. Int Ophthalmol Clin. 2016;56(3):1–28.

    Article  PubMed  Google Scholar 

  10. Al-Hity A, Ramaesh K, Lockington D. EDTA chelation for symptomatic band keratopathy: results and recurrence. Eye. 2018;32(1):26–31.

    Article  CAS  PubMed  Google Scholar 

  11. Kwon YS, Song YS, Kim JC. New treatment for band keratopathy: superficial lamellar keratectomy, EDTA chelation and amniotic membrane transplantation. J Korean Med Sci. 2004;19(4):611–5.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sheppard JD, Mansur A, Comstock TL, Hovanesian JA. An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clin ophthalmol (Auckland, NZ). 2014;8:1105.

    Article  CAS  Google Scholar 

  13. Friend J, Thoft RA. Functional competence of regenerating ocular surface epithelium. Invest Ophthalmol Vis Sci. 1978;17(2):134–9.

    CAS  PubMed  Google Scholar 

  14. John T, Tighe S, Sheha H, Hamrah P, Salem ZM, Cheng A, et al. Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease. J Ophthalmol. 2017;2017:1–10.

    Article  Google Scholar 

  15. Nakamura T, Kataoka T, Kojima T, Yoshida Y, Sugiyama Y. Refractive outcomes after phototherapeutic refractive keratectomy for granular corneal dystrophy. Cornea. 2018;37(5):548–53.

    Article  PubMed  Google Scholar 

  16. Rathi VM, Vyas SP, Sangwan VS. Phototherapeutic keratectomy. Indian J Ophthalmol. 2012;60(1):5–14.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Eastern Virginia Medical School, Norfolk, VA, USA

    Sina Vahedi

  2. Virginia Eye Consultants, 241 Corporate Boulevard, Suite #210, Norfolk, VA, 23502, USA

    John D. Sheppard

Authors
  1. Sina Vahedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John D. Sheppard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John D. Sheppard.

Ethics declarations

Conflict of Interest

John D. Sheppard reports personal fees and other from Alcon/Novartis, personal fees and other from Allergan, personal fees and other from Bausch + Lomb, personal fees and other from KALA Pharmaceuticals, personal fees from Omeros, and personal fees from Johnson & Johnson/TearScience, outside the submitted work. Sina Vahedi declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Cataract

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vahedi, S., Sheppard, J.D. Advanced Technology IOL Cataract Surgery Optimized for Pre-existing Corneal Disease. Curr Ophthalmol Rep 6, 237–240 (2018). https://doi.org/10.1007/s40135-018-0188-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40135-018-0188-x

Keywords

Search

Navigation